All Stories

  1. Human suicide, biomedical knowledge and therapeutic advances
  2. COVID-19 Research, Public Health and Biomedical Basis
  3. Anticancer Drug Development: Evaluative Architecture
  4. COVID-19 Study: A New Principle Discovery
  5. COVID-19 Study, Diagnostic and Therapeutic Transition
  6. Antimetastatic Drug, Pharmacologic Challenge and Opportunity
  7. Bone Metastasis Diagnosis, Blood Biomarker Detections
  8. Anti-metastatic drug development, overview and perspectives
  9. Educational Perspectives for Nursery
  10. Drug Sensitivity Testing for Cancer Therapy, Technique Analysis and Trends
  11. Pulmonary nodules, is there any pathogenesis evidence?
  12. HIV/AIDS Curability Study, Different Approaches and Drug Combination
  13. Pulmonary nodules, surgery or other medication
  14. Bone Metastasis and Circulation Biomarkers Profiling Towards Personalized Cancer Medicine
  15. Pulmonary Nodules, Surgery or Other Medication
  16. Anti-Metastatic Drug Developments, Utility of More Animal Models
  17. Several approaches for anticancer drug development progress
  18. Drug Sensitivity Testing for Cancer Therapy, Key Areas
  19. COVID-19 infection for metabolic abnormal human beings
  20. Fundamental knowledge for nurses 
  21. Nursery promotion, education and system updating
  22. Cancer Bone Metastasis, Diagnostic Insights and Drug Selection
  23. Cancer Bone Metastasis, Experimental Study
  24. Neuropsychiatric Approaches for Human Suicide Prediction and Management
  25. Osteoporosis Targeting, Possible Breakthroughs
  26. Neuropsychiatric insights for human suicide
  27. Bone Cancer and Metastasis Trials, Drug Treatment
  28. Neurobiology for human suicide
  29. Bone Disease Treatment Study, Major Pathways
  30. Pathology Study for Human Suicide
  31. Nursery activity and quality, chemistry between doctors and nurses
  32. Nursery education, narrow-range or wide-range
  33. Anticancer drug development, challenge and dilemma
  34. Life Origin on Earth, Knowledge Development
  35. HIV/AIDS treatment, therapeutic strategy break throughs
  36. Suicide Risks and Prevention, Neuropathogenic Study
  37. Medical Treatments for Chronic or Aggressive Diseases, Palliative Therapy and Nursery
  38. General information for nursery
  39. Historical analysis of suicide
  40. Drug sensitivity testing, a unique drug selection strategy
  41. Life Origin on Earth, Biochemical Approaches
  42. Herbal medicine in new era
  43. Nursery service, quality promotion
  44. Patient’s care and nursery in different diseases
  45. New HIV/AIDS Therapeutics
  46. Nursery Service in Modern Days
  47. Cancer Bioinformatics in Cancer Therapy
  48. Individualized Cancer Therapy
  49. Type 2 Diabetes Treatment and Drug Development Study
  50. Hypotheses for Life Origin on Earth, Comparison and Validation
  51. Type 2 Diabetes Study, Introduction and Perspective
  52. Anthocyanins and its biological & therapeutic characters
  53. A Critical Appraisal of Different Food Safety and Quality Management Tools to Accomplish Food Safety
  54. Pathology and treatments of obesity
  55. Obesity, Risks and Managements
  56. Keep up the pace of drug development evolution and expenditure
  57. Diabetes Mellitus and Male Aging: Pharmacotherapeutics and Clinical Implications
  58. Drug Combination in Clinical Cancer Treatments
  59. General outlook for individualized cancer therapy
  60. Ebola origin and treatment
  61. Cancer Bioinformatics for Updating Anticancer Drug Developments and Personalized Therapeutics
  62. HAART in HIV/AIDS Treatments
  63. Anticancer Drug Development, System Updating and Global Participations
  64. Human suicide study, major disciplines and treatment outcomes
  65. Anticancer drug development
  66. HIV in Human Genomes and Therapeutics
  67. HIV Biotherapy and Natural Chemotherapeutic Agents
  68. Anticancer Drug Combinations, How Far We can Go Through?
  69. Antimetastatic therapy at aberrant sialylation in cancer cells, a potential hotspot
  70. Life Origin on Earth, Insights among Different Arguments
  71. Cancer metastasis treatment, a key drawbacks
  72. The suicide treatment, a new model
  73. HIV Vaccine for Prevention and Cure, A Mission Possible
  74. Zika Therapy
  75. HIV vaccine
  76. Discover Natural Chemical Drugs in Modern Medicines
  77. Mathematics in biomedical science
  78. The origin of HIV
  79. Human suicide study
  80. Pharmacogenetics of Cancer Therapy
  81. Anticancer Drug Sensitivity Testing
  82. New Perspectives of HIV/AIDS Therapy Study
  83. Antidepressant treatment study
  84. Clinical neoplasm metastasis treatments according to patient's personal conditions.
  85. Assistant cancer treatments in the clinic
  86. Drug sensitivity testing in clinical cancer treatments
  87. Anticancer drug combination in the clinic
  88. Anticancer drug pharmacogenomics in cancer chemotherapy
  89. Cost-effectiveness for personalized cancer therapy
  90. Conclusion
  91. Introduction
  92. Discussion
  93. Cancer biomarker/bioinformatics detection in clinical cancer treatments
  94. Anti-diabetic treatments
  95. Anticancer Drug Combinational Study
  96. The Origins of HIV
  97. Anti-diabetic treatments, patho-therapeutic relation
  98. Origin of Ebola, hypothesis
  99. Personalized Cancer Therapy: A Perspective
  100. Pharmacogenomics in human suicide prediction and treatments
  101. Cancer metastasis treatment study and drug developments
  102. Challenge for HIV/AIDS therapy
  103. Cost-effectiveness Considerations of Individualized Cancer Chemotherapy
  104. Drug Combinations in Cancer Treatments
  105. New Insights into Individualized Antimetastatic Therapy
  106. Anticancer drugs on serum sialic acid level in mice bearing LLC
  107. Genetics in Neural Toxicity of Drugs
  108. Avian flu, pathogenesis and therapeutic study
  109. First Genetic Information Replication in Life Origin on Earth
  110. Origins of Life, A New Cooperative Model
  111. Cancer Metastases and Clinical Therapies
  112. Origins of Life, RNA world or alternative RNA world
  113. Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
  114. Individualized Cancer Chemotherapy by Detecting Cancer Biomarkers
  115. Antimetastatic Therapies according to Metastatic Cascade
  116. Genetics in antidepressant-induced suicide
  117. Pathology of Drug-induced mania & suicide
  118. Influenza treatment
  119. High Active Anti-retroviral Therapy for HIV/AIDS, Progresses and Drawback
  120. Individualized cancer chemotherapy
  121. High Active Antiretroviral Therapy for HIV/AIDS-Early Intervention or Later Intervention?
  122. Genomic study of antidepressant-induced suicide
  123. Aberrant sialylation in tumor cells
  124. Anti-mobility of Bisdioxopiperanes against human mammary tumors
  125. Antimetastatic activity and mechanisms of action of Bisdioxopiperazine compounds
  126. Neural toxicity of drugs
  127. Anticancer activity and mechanisms of Bisdioxopiperazines
  128. Different Spontaneous Pulmonary Metastasis Inhibitions against Lewis Lung Carcinoma in Mice by Bisdioxopiperazine Compounds of Different Treatment Schedules
  129. 14C-probimane in the mice bearing LLC
  130. Unsatisfactory design of human AIDS genome research
  131. Antidepressant in Cancer Treatment
  132. AIDS and human genome studies, from a hypothesis to systematic approaches
  133. Antidepressants in Human suicide
  134. Mathematical model in therapeutic risk prediction
  135. Fibrinogen in neoplasm metastasis
  136. Sequencing the whole genome of infected human cells obtained from diseased patients – a proposed strategy for understanding and overcoming AIDS or other deadest virus-infected diseases
  137. Relationship Between Blood Fibrinogen Concentration and Pathological Features of Cancer Patients: A 139-case Clinical Study
  138. Medicinal Chemistry of Probimane and MST-16: Comparison of Anticancer Effects Between Bisdioxopiperazines
  139. Individualized cancer chemotheray
  140. Anti-proliferative and chromosome segregation by probimane and MST-16
  141. Effect of Anti-Cancer Drugs on the Binding of 125I-Fibrinogen to Two Leukaemia Cell Lines In Vitro
  142. Antitumor effects of two bisdioxopiperazines against two experimental lung cancer models in vivo
  143. Inhibition of probimane on lipid peroxidation of rabbit and human erythrocytes
  144. Aberration of sialylation in neoplasm metastasis and possible therapeutics
  145. Effects of Cancer Chemotherapy on the Blood Fibrinogen Concentrations of Cancer Patients
  146. Effect of magnetized water on the mice given high doses of antineoplastic drugs
  147. Inhibition of probimane on lipoperoxidation of human red cells in vitro
  148. Enzyme dynamic study on calmodulin Ca++-Mg++-ATPase system of red blood cells inhibited by α-anordrin and probimane
  149. Journal of Clinical and Medical Reviews